Blake E. Michener

Array ( [id] => 3113968 [patent_doc_number] => 05409897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-25 [patent_title] => 'Cysteine-modified acidic fibroblast growth factor and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/189230 [patent_app_country] => US [patent_app_date] => 1994-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14747 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/409/05409897.pdf [firstpage_image] =>[orig_patent_app_number] => 189230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3421467 [patent_doc_number] => 05389537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-14 [patent_title] => 'Nuclease having altered specificity' [patent_app_type] => 1 [patent_app_number] => 8/184604 [patent_app_country] => US [patent_app_date] => 1994-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5641 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/389/05389537.pdf [firstpage_image] =>[orig_patent_app_number] => 184604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3052069 [patent_doc_number] => 05344783 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-06 [patent_title] => 'Platelet aggregation inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/091392 [patent_app_country] => US [patent_app_date] => 1993-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 7570 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/344/05344783.pdf [firstpage_image] =>[orig_patent_app_number] => 091392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3421175 [patent_doc_number] => 05389517 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-14 [patent_title] => 'Specific antibodies against the DNA-binding domain of and immunoassays to determine the presence and functional status of estrogen receptor proteins' [patent_app_type] => 1 [patent_app_number] => 8/077880 [patent_app_country] => US [patent_app_date] => 1993-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 45 [patent_no_of_words] => 15079 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/389/05389517.pdf [firstpage_image] =>[orig_patent_app_number] => 077880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3454480 [patent_doc_number] => 05378687 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-03 [patent_title] => 'Use of human blood coagulation factor XIII for the treatment of ulcerative colitis' [patent_app_type] => 1 [patent_app_number] => 8/060702 [patent_app_country] => US [patent_app_date] => 1993-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2127 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/378/05378687.pdf [firstpage_image] =>[orig_patent_app_number] => 060702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3105860 [patent_doc_number] => 05418156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-23 [patent_title] => 'Agarase enzyme system from alteromonas strain 2-40' [patent_app_type] => 1 [patent_app_number] => 8/057022 [patent_app_country] => US [patent_app_date] => 1993-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9276 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/418/05418156.pdf [firstpage_image] =>[orig_patent_app_number] => 057022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3093804 [patent_doc_number] => 05312911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-17 [patent_title] => 'Cysteine-modified acidic fibroblast growth factor' [patent_app_type] => 1 [patent_app_number] => 8/030510 [patent_app_country] => US [patent_app_date] => 1993-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14770 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/312/05312911.pdf [firstpage_image] =>[orig_patent_app_number] => 030510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3070028 [patent_doc_number] => 05336613 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-09 [patent_title] => 'Cephalosporin C acylase' [patent_app_type] => 1 [patent_app_number] => 8/019870 [patent_app_country] => US [patent_app_date] => 1993-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 13298 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/336/05336613.pdf [firstpage_image] =>[orig_patent_app_number] => 019870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3054759 [patent_doc_number] => 05344919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-06 [patent_title] => 'Integrin from human epithelial cells' [patent_app_type] => 1 [patent_app_number] => 8/014090 [patent_app_country] => US [patent_app_date] => 1993-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10013 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/344/05344919.pdf [firstpage_image] =>[orig_patent_app_number] => 014090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3458987 [patent_doc_number] => 05382519 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-17 [patent_title] => 'Periplasmic 3\':5\'-cyclic nucleotide phosphodiesterase and related methods for producing and using the same' [patent_app_type] => 1 [patent_app_number] => 8/004751 [patent_app_country] => US [patent_app_date] => 1993-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4247 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/382/05382519.pdf [firstpage_image] =>[orig_patent_app_number] => 004751 [rel_patent_id] =>[rel_patent_doc_number] =>)